Cite
Comprehensive Comparative Effectiveness and Safety of First-Line β-Blocker Monotherapy in Hypertensive Patients: A Large-Scale Multicenter Observational Study.
MLA
Chan You, Seng, et al. “Comprehensive Comparative Effectiveness and Safety of First-Line β-Blocker Monotherapy in Hypertensive Patients: A Large-Scale Multicenter Observational Study.” Hypertension (0194911X), vol. 77, no. 5, May 2021, pp. 1528–38. EBSCOhost, https://doi.org/10.1161/HYPERTENSIONAHA.120.16402.
APA
Chan You, S., Krumholz, H. M., Suchard, M. A., Schuemie, M. J., Hripcsak, G., Chen, R., Shea, S., Duke, J., Pratt, N., Reich, C. G., Madigan, D., Ryan, P. B., Woong Park, R., & Park, S. (2021). Comprehensive Comparative Effectiveness and Safety of First-Line β-Blocker Monotherapy in Hypertensive Patients: A Large-Scale Multicenter Observational Study. Hypertension (0194911X), 77(5), 1528–1538. https://doi.org/10.1161/HYPERTENSIONAHA.120.16402
Chicago
Chan You, Seng, Harlan M. Krumholz, Marc A. Suchard, Martijn J. Schuemie, George Hripcsak, RuiJun Chen, Steven Shea, et al. 2021. “Comprehensive Comparative Effectiveness and Safety of First-Line β-Blocker Monotherapy in Hypertensive Patients: A Large-Scale Multicenter Observational Study.” Hypertension (0194911X) 77 (5): 1528–38. doi:10.1161/HYPERTENSIONAHA.120.16402.